Medical students' syndrome (MSS) is a set of psychosomatic symptoms that affect students due to their medical background knowledge.  This study aims to measure the prevalence and assess the knowledge about MSS among medical students at the University of Sharjah. It also aims to compare the attributed characteristics of MSS between different years of study.  A self-administered 24-item questionnaire was distributed to 503 students enrolled in the College of Medicine at University of Sharjah using nonprobability convenience sampling during June 2021. A total of 472 responses were completed and analyzed using descriptive studies and chi-squared test.  The prevalence of MSS in this study was found to be 70.8% (  = 334). Clinical year students were 1.75 times more likely to have felt they had a disease they studied about (95% confidence interval: 1.05-2.90,  = 0.03).  Medical students are more likely to experience MSS as their education progresses.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10361401PMC
http://dx.doi.org/10.1055/s-0043-1768683DOI Listing

Publication Analysis

Top Keywords

university sharjah
12
students' syndrome
8
medical students
8
students university
8
students
6
mss
5
medical
4
medical students'
4
syndrome medical
4
sharjah uae
4

Similar Publications

The p53-MDM2 pathway plays a crucial role regulating tumor suppression and is a focal point of cancer research. This literature review delves into the complex interplay between the tumor suppressor protein p53 and its main regulator MDM2, highlighting their interaction and implications in cancer development and progression. The review compiles and summarizes the existing understanding of the biology and regulation of p53 and MDM2, emphasizing their roles in various cellular processes, including cell cycle regulation, DNA repair, apoptosis, and metabolism.

View Article and Find Full Text PDF

Introduction: Gestational Diabetes Mellitus (GDM) is a metabolic disorder marked by Q10 hyperglycemia that can negatively affect both mothers and newborns. The increasing prevalence of GDM and the limitations associated with the standard diagnostic test highlight the urgent need for early screening strategies that promote timely interventions.

Methods: This study aims to investigate the metabolic profile associated with GDM through an untargeted metabolomic analysis using mass spectrometry (MS)- based omics.

View Article and Find Full Text PDF

The search for effective anti-cancer therapies has led to the exploration of dual inhibition strategies targeting multiple key molecular pathways. In this study, we aimed to design a novel candidate capable of dual inhibition targeting both EGFR (Epidermal Growth Factor Receptor) and PARP-1 (poly(ADP-ribose)polymerase-1), two crucial proteins implicated in cancer progression and resistance mechanisms. Through molecular hybridization and structure-based drug design approaches, we synthesized a series of compounds based on spirooxindole with triazole scaffolds with the potential for dual EGFR and PARP-1 inhibition.

View Article and Find Full Text PDF

This study explores the integration of nanotechnology and Long Short-Term Memory (LSTM) machine learning algorithms to enhance the understanding and optimization of fuel spray dynamics in compression ignition (CI) engines with varying bowl geometries. The incorporation of nanotechnology, through the addition of nanoparticles to conventional fuels, improves fuel atomization, combustion efficiency, and emission control. Simultaneously, LSTM models are employed to analyze and predict the complex spray behavior under diverse operational and geometric conditions.

View Article and Find Full Text PDF

Purpose/aim Of The Study: There is limited real-world evidence regarding the effectiveness and safety of dupilumab in Gulf countries. The study aimed to evaluate atopic dermatitis (AD) disease control in adult and adolescent patients (≥12 years) treated with dupilumab in Gulf countries.

Materials And Methods: This observational study included patients with moderate-to-severe AD who initiated dupilumab within 30 days.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!